Bioactive Combination Therapy for Parkinson's Symptom and Progression Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for movement disorders, such as Parkinson's disease, are inadequate in reversing symptoms, slowing disease progression, and addressing non-motor symptoms, and often involve invasive procedures like Deep Brain Stimulation.
Innovation Solution
Therapeutic combinations of bioactive molecules from fungi, plants, and algae, including psilocybin-producing fungi, Cannabis, Dipteryx, and marine algae, formulated into pharmaceutical compositions for oral and parenteral administration, targeting specific bioactive molecules like psilocybin, THC, CBD, and coumarin to treat movement disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current therapies are used to treat movement disorders, then symptoms can be eased, but function cannot be restored and disease progression cannot be appreciably slowed
Solution Approach 1:
The patent combines multiple bioactive molecules from different sources (psilocybin from fungi, cannabinoids from plants, compounds from algae) into a single therapeutic composition. This synergistic combination aims to achieve both symptom relief and disease progression reversal, overcoming the limitations of single-agent therapies.
Solution Approach 2:
The therapeutic composition is a composite formulation containing multiple distinct bioactive compounds with different mechanisms of action. This composite approach allows the treatment to address both motor and non-motor symptoms while potentially reversing disease progression, thereby resolving the contradiction between symptom management and disease modification.
2Reliability
If Deep Brain Stimulation is used to treat movement disorders, then symptoms can be managed, but the treatment is invasive
Solution Approach 1:
The patent replaces the mechanical/electrical intervention of Deep Brain Stimulation with a pharmacological approach using orally or parenterally administered bioactive molecules. This substitution eliminates the need for surgical implantation while maintaining effective symptom management through biochemical mechanisms.
Solution Approach 2:
The therapeutic composition acts as a chemical intermediary that mediates the treatment effect without requiring direct physical or electrical stimulation of the brain. The bioactive molecules travel through the bloodstream and exert their effects systemically, providing a non-invasive alternative to DBS.
3Adaptability or versatility
If current therapies are used to treat movement disorders, then motor symptoms can be addressed, but non-motor symptoms cannot be treated
Solution Approach 1:
The patent designs a universal therapeutic composition that simultaneously addresses multiple types of symptoms including motor symptoms (tremor, rigidity, bradykinesia) and non-motor symptoms (cognitive impairment, mood disorders, sleep disturbances). Each bioactive component contributes to different therapeutic effects, making the single formulation versatile enough to treat the full spectrum of movement disorder manifestations.
Data Source
AI summary
Provided are therapeutic combinations, pharmaceutical compositions, and pharmaceutical kits comprising bioactive molecules from fungi, plants, and algae. In some embodiments, the fungi are from any psilocybin-producing fungi, such as from Psilocybe spp. fungi. In some embodiments, the plants are from either or both of the Cannabis and Dipteryx genera. In some embodiments, the algae may be marine algae, such as from the family Bangicacae, including the Pyropia and Porphyra genera. Methods of producing the disclosed combinations, compositions, and kits are also provided, such as using natural, biosynthetic, or synthetic means. Further provided are methods of using the disclosed combinations, compositions, and kits in treatment, and in particular for movement disorders, such as for Parkinson's disease, and the disclosed combinations are demonstrated to provide significant advantages in the treatment thereof.